Table 1.
Half-maximal concentrations for Cd activation and inhibition
ConstructEC50 (µM)Slope, nIC50 (mM)Slope, bCells (no.)
K2(Q) WT (KA-evoked)   0.89 ± 0.08 1.1 ± 0.1 
K2(R) WT (KA-evoked)   0.25 ± 0.04 1.0 ± 0.1 
K2(Q&R) A8C 7.3 ± 1.4 1.6 ± 0.4 25 ± 5.4 1.3 ± 0.4 23 
K2(Q) L10C 1,800 ± 300 1.2 ± 0.2 26 ± 7.1 1.9 ± 0.5 12 
N1/K2 A8C + N2B/K2 A8C 5.6 ± 1.7 0.9 ± 0.1 1.1 ± 0.2 1.8 ± 0.4 21 
N1/K2 A8C + N2B/K2 47 ± 8 1.0 ± 0.2 13 ± 10 0.9 ± 0.4 14 
N1/K2 + N2B/K2 A8C 27 ± 9 0.9 ± 0.1 1.1 ± 0.2 1.8 ± 0.4 14 
ConstructEC50 (µM)Slope, nIC50 (mM)Slope, bCells (no.)
K2(Q) WT (KA-evoked)   0.89 ± 0.08 1.1 ± 0.1 
K2(R) WT (KA-evoked)   0.25 ± 0.04 1.0 ± 0.1 
K2(Q&R) A8C 7.3 ± 1.4 1.6 ± 0.4 25 ± 5.4 1.3 ± 0.4 23 
K2(Q) L10C 1,800 ± 300 1.2 ± 0.2 26 ± 7.1 1.9 ± 0.5 12 
N1/K2 A8C + N2B/K2 A8C 5.6 ± 1.7 0.9 ± 0.1 1.1 ± 0.2 1.8 ± 0.4 21 
N1/K2 A8C + N2B/K2 47 ± 8 1.0 ± 0.2 13 ± 10 0.9 ± 0.4 14 
N1/K2 + N2B/K2 A8C 27 ± 9 0.9 ± 0.1 1.1 ± 0.2 1.8 ± 0.4 14 

or Create an Account

Close Modal
Close Modal